two. There is no evidence to support the routine use of anticoagulants or antiplatelet drugs for the treatment of ICAD" (7) . However, as pointed out in a recent review in The New England Journal of Medicine (8) , there is some indirect evidence of the appropriateness of anticoagulation with intravenous heparin followed by oral warfarin for patients with acute dissections of the carotid or vertebral arteries. We describe a case of a young patient affected by vertebral artery dissection treated with low-molecular-weight heparin (LMWH) with a favorable outcome.
CASE REPORT
A 6-year-old boy was admitted to our hospital complaining of difficulty walking and impaired speech. There was no history of important head trauma, although his mother did report a minor accident in which the child had struck his head approximately 1 week earlier, without loss of consciousness, followed the day after by a single episode of vomiting. The patient was not using any medications. The medical history for familial thrombophilia or venous thromboembolic episodes was negative.
On admission, he was an alert, afebrile, normotensive, right-handed boy with intact mental status and higher cortical functions, although his speech was less fluent than usual. Physical examination was not contributory. The neurologic examination was characterized by clumsiness and mild imbalance on walking, slowness of speech, slightly increased osteotendon reflexes, and a normal cranial nerve examination.
A computed tomography scan revealed a hypodense area in the median-paramedian right pontine region; magnetic resonance angiography (MRA) confirmed the ischemic nature of cerebellar lesions. Catheter angiography showed complex dissection of the left vertebral artery at the C2 level region with consequent basilar artery thrombosis (distal basilar clot).
The patient was given subcutaneous LMWH at therapeutic doses (enoxaparin, 100 IU/kg twice daily), as recently suggested for the treatment of subacute ischemic stroke and cerebral vein thrombosis (9,10), and was discharged after 1 week of hospital stay. LMWH was continued at the same dosage at home for 3 weeks, and then reduced to a prophylactic regimen (2,000 IU/day) for 3 more weeks. After this time MRA showed resolution of the dissection and complete recanalization of the left basilar artery. The patient recovered completely and is now well and out of treatment.
An evaluation for either congenital or acquired thrombophilia was performed, including dosage of AT III, protein C, protein S, and homocysteinemia, as well as a search for factor V Leiden and prothrombin gene G20210A mutations, lupus anticoagulant, and anticardiolipin antibodies; no thrombophilic defects were identified.
DISCUSSION
This case raises important issues in the management of vertebral artery dissection. The lack of randomized trials gives the physician the difficult choice of treatment, if any, to these patients. Most dissections of the carotid and vertebral arteries heal spontaneously (8) ; on the other hand, recurrent embolic infarcts or progressive thrombosis of basilar artery develops despite anticoagulant or antiaggregating treatment (2) .
The dissection and the subsequent thrombosis markedly reduce the blood flow, so that the rheology of involved vessels may resemble that of the venous system, in which plasmatic factors prevail over platelets in determining thrombosis. Antiplatelet therapy is not recommended for the treatment of venous thrombosis (11) . On these grounds, anticoagulant agents seem to be a better treatment to break down the life-threatening vicious circle thrombosis-stasis-thromboembolism in dissected arteries.
There have been few reports of children treated with intravenous unfractioned heparin for vertebrobasilar occlusion with good results (3). This therapy, however, is cumbersome, requires tight control of coagulation parameters, and carries a significant hemorragic risk. LMWH preparations offer definitive advantages compared to unfractioned heparin: they do not require continuous infusion, are probably safer, and allow treatment of venous thromboembolism at home on a weight-adjusted dosing without laboratory monitoring (12) . The latter feature is particularly important in pediatric patients, allowing a reduction of the psychological troubles resulting from a prolonged hospital stay. We defined the dosage of enoxaparin to be used according to previous reports on other neurologic, although different, diseases (9, 10) .
LMWH administration is often followed by treatment with oral anticoagulants (8) , but in this case we chose a long-term out-of-hospital treatment with LMWH considering the difficulty with adequate compliance to oral anticoagulant therapy in children.
A recent trial compared aspirin with LMWH for the treatment of pediatric patients with a first ischemic stroke (13) . The study provided evidence of the safety of LMWH, although failed to demonstrate the superiority of LMWH versus aspirin for the secondary prevention of stroke. The end point of this study was, however, the recurrence of ischemic stroke, and it does not give information about the outcome of patients affected by cerebral artery dissection in terms of recanalization of the involved vessels.
In our experience, LMWH has been a safe and useful therapy for thrombosis accompanying vertebral artery dissection; the improvement of radiologic and clinical findings in this patient following treatment was dramatic and impressive. The decision to start anticoagulant therapy should be individualized, carefully balancing hemorrhagic and thromboembolic risks. Nevertheless this report suggests that LMWH therapy should be regarded as the first choice when thrombosis of vessels downstream of dissection point is a prominent feature, and the patient carries a low hemorrhagic risk.
